Fox Rothschild LLP

A counterclaim plaintiff’s claims in a complex trade secret action involving the development of cell-cultured human milk suffered a rather pedestrian fate given the important technological stakes. The counterclaim defendants had actual notice of the claims, but defective service under Rule 4 ended them before they began.

In BIOMILQ, Inc. v. Guiliano, 2023 NCBC 91A